U.S. Water Utilities Stock News

If you are wondering whether Kohl's current share price offers value or risk, you are not alone. This article focuses squarely on what the numbers say about the stock. Kohl's recent share price paints a mixed picture, with a 7.4% decline over the last week and a 12.0% decline over the last month, but a 68.0% gain over the past year and a smaller 4.0% decline year to date. Recent headlines around Kohl's have centered on broader questions about department store relevance, the impact of...

If you are wondering whether CoreCivic’s share price still offers value at around US$19.94, you are not alone. This article focuses squarely on what that price could mean for investors. The stock has returned 5.2% over the last 7 days, 5.5% over the last 30 days, 4.8% year to date, while its 1 year return of a 10.7% decline sits against a 76.8% return over 3 years and 173.9% over 5 years. Recent headlines around CoreCivic have continued to keep the company in focus, with investors weighing...

Thermon Group Holdings (THR) recently reported second quarter 2025 results, with earnings and revenue coming in above expectations. This financial update coincided with the stock touching a new all time high of $41.32. See our latest analysis for Thermon Group Holdings. The latest move to a new all time high comes after a strong 90 day share price return of 49.91%, while the 1 year total shareholder return of 42.89% and 5 year total shareholder return of 142.04% point to building momentum...

Crinetics Pharmaceuticals recently completed a US$350.14 million follow-on common stock offering after reporting over US$5 million in preliminary fourth-quarter 2025 PALSONIFY revenue and positive Phase 2 atumelnant data in classic congenital adrenal hyperplasia. Together, these updates highlight early commercial traction for PALSONIFY and clinical progress for atumelnant, while the equity raise may bolster Crinetics’ ability to fund further development and commercialization. We’ll now...

If you are wondering whether ServiceNow's current share price reflects its underlying worth, you are not alone. Many investors are asking the same question right now. The stock closed at US$138.19, with returns of a 7.1% decline over 7 days, a 20.1% decline over 30 days, a 6.3% decline year to date, a 33.0% decline over 1 year, a 65.2% gain over 3 years and a 33.0% gain over 5 years. Recent coverage has focused on how ServiceNow fits into long term trends in enterprise software and workflow...

Delta Air Lines (DAL) has just wrapped up FY 2025 with Q4 revenue of US$16.0b and basic EPS of US$1.88, alongside net income excluding extra items of US$1,219m. Over the past year, revenue on a trailing twelve month basis moved from US$61.6b with EPS of US$5.39 to US$63.4b with EPS of US$7.72, while trailing net income excluding extra items rose from US$3,457m to US$5,005m. For investors, the current earnings outline a picture of firmer margins and profitability that now need to be weighed...

Event backdrop and recent share performance Talen Energy (TLN) has been drawing attention after a mixed pattern in its recent share performance, with a gain over the past month alongside a decline over the past 3 months and year to date. See our latest analysis for Talen Energy. At a share price of $376.86, Talen Energy’s short term share price performance has been choppy, yet its 1 year total shareholder return of 71.11% points to strong longer term momentum. This may reflect shifting views...

Power Solutions International was recently highlighted as an affordable growth stock, backed by strong earnings momentum, positive forward estimates, and a solid balance sheet. This recognition emphasizes that the company’s expansion is underpinned more by profitability and financial strength than by heavy reliance on debt. We’ll now explore how this focus on earnings growth supported by a resilient balance sheet shapes Power Solutions International’s investment narrative. The latest GPUs...

If you are wondering whether Prosperity Bancshares at around US$71.35 is offering fair value or a potential bargain, you are in the right place. The stock has had mixed recent returns, with about 0.5% over the last week, a 2.0% decline over the last month, a 2.5% gain year to date, and a 4.9% decline over the past year. Over longer periods, returns have been 6.3% over three years and 19.2% over five years. Recent attention on regional banks and their balance sheet strength has put names like...

Recent commentary on CarMax (KMX) has focused on weakening same-store sales, market share pressures from rivals, thinner gross margins versus peers, and elevated leverage. These factors have drawn fresh attention to the stock. See our latest analysis for CarMax. The recent concerns around same-store sales, market share and leverage sit against a share price that has moved to US$46.45, with a 7 day share price return of 13.49% and an 18.22% year to date share price return. The 1 year total...

Pilgrim's Pride (PPC) has recently attracted investor attention after its shares closed at US$40.41. This has prompted a closer look at how the company’s current valuation lines up with its recent financial profile. See our latest analysis for Pilgrim's Pride. That US$40.41 share price comes after a 7-day share price return of 7.62% and a 90-day share price return of 5.95%, while the 5-year total shareholder return of 146.27% points to a much stronger long-run journey. If Pilgrim’s Pride has...

In early January 2026, ADMA Biologics raised its preliminary 2025 and 2026 revenue guidance to about US$510–US$511 million and US$635 million, respectively, while also issuing new long-range revenue targets of roughly US$775 million for 2027 and more than US$1.10 billion for 2029. The company also highlighted yield-enhanced production, plasma network repositioning, and progress on its SG-001 program as levers to support margin expansion, supply security, and future product...

If you are wondering whether CompoSecure shares still offer value after recent attention, this article walks through what the current price might be implying about the business. The stock last closed at US$21.43, with total returns of 7.8% over 7 days, 6.0% over 30 days, 14.8% year to date, 83.0% over 1 year and a very large gain over 3 years that is around 4x, plus 157.6% over 5 years. Recent coverage has focused on CompoSecure's role in payment card and security products, along with how...

Earlier this month, IREN Limited filed a shelf registration for approximately US$661.0 million covering 17,500,000 ordinary shares in an ESOP-related offering, while advancing its shift from Bitcoin mining toward AI cloud infrastructure under a multi‑year AI data center contract with Microsoft. This combination of fresh equity capacity and a large, long-term hyperscaler agreement underlines how IREN is funding and scaling its move into high-performance AI compute services alongside its...

In early January 2026, Abbott Laboratories launched Libre Assist, a new generative AI feature within its Libre app that helps people with diabetes in the U.S. predict how specific foods may affect their glucose levels and then compares those predictions with post-meal data from Libre continuous glucose monitoring sensors. This move highlights Abbott’s push to integrate AI-driven decision support directly into everyday diabetes management, potentially deepening user engagement with the...

If you are wondering whether Compañía de Minas BuenaventuraA’s recent share price puts it on the expensive side or still leaves room for value, you are not alone. The stock last closed at US$34.34, with returns of 13.9% over 7 days, 21.9% over 30 days, 20.1% year to date and 175.5% over the past year, as well as 353.9% over 3 years and 230.1% over 5 years. Investors have been reacting to ongoing market interest in metals and mining companies and shifting sentiment toward producers with...

Robust financial results put Sezzle (SEZL) in focus Recent attention around Sezzle (SEZL) centers on its strong financial results, where revenue growth has been paired with even faster earnings expansion. This combination signals efficient scaling and sharpened profitability. See our latest analysis for Sezzle. Sezzle’s shares now trade at US$76.26. Even with a 2.2% decline in the 3 month share price return, the 7 day share price return of 6.26% and the year to date share price return of...

If you are wondering whether Novo Nordisk is fairly priced or if the recent buzz has pushed it too far, this article walks through what the numbers actually say about the stock. Over the past week the share price moved 6.0%, over 30 days it was 18.9%, year to date it is 13.8%, while the 1 year and 3 year returns are 25.1% and 11.0% declines, compared to a 73.6% gain over 5 years. Recent headlines have kept Novo Nordisk in the spotlight, with ongoing attention on its role in treatments that...

If you are wondering whether Agnico Eagle Mines is priced attractively after a big run, this article will walk through what the current share price might be implying about value. The stock last closed at US$199.08, with returns of 10.2% over 7 days, 18.3% over 30 days, 16.8% year to date and 140.2% over the past year; recent price action has been very strong. Recent headlines around Agnico Eagle Mines have focused on broader interest in gold related equities and ongoing attention on miners...

If you are wondering whether Realty Income is priced attractively right now, this article will walk through what the current share price could mean for long term investors. The stock closed at US$59.23 most recently, with returns of 3.2% over the last 7 days, 2.6% over 30 days, 3.4% year to date, 17.9% over 1 year, 4.5% over 3 years and 35.3% over 5 years. Recent coverage has focused on Realty Income as a large, dividend paying real estate investment trust. It is commonly viewed as an income...

What Williams Companies' Recent Performance Tells Investors Williams Companies (WMB) has quietly put together a mixed return profile, with gains over the past year and past 3 years, but a roughly 5% decline over the past 3 months that may catch your eye. See our latest analysis for Williams Companies. At a share price of US$60.49, Williams Companies has seen short term momentum ease, with a 90 day share price return of a 5.16% decline. However, its 1 year total shareholder return of 7.79% and...

In recent days, Lockheed Martin has highlighted operational progress at its F-35 production facility, welcomed senior U.S. defense leadership, and signed a framework agreement with the Department of War to accelerate PAC-3 Missile Segment Enhancement deliveries, while broader sector headlines underscored both heightened demand and policy uncertainty for defense contractors. Together with a record delivery of 191 F-35 jets in 2025 and a growing order backlog, these developments underscore how...

Earlier this month, Rigetti Computing revised its roadmap and pushed general availability of its 108-qubit Cepheus-1-108Q system to around the end of the first quarter of 2026, citing technical work on tunable couplers and an additional chip iteration to improve fidelity in what will be its highest qubit-count modular machine to date. The delay underscores how advanced features like tunable couplers and a twelve–chiplet modular architecture are becoming critical differentiators, but also...

Gilead Sciences (GILD) is back in focus after management used the J.P. Morgan Healthcare Conference to spotlight its broad HIV portfolio, upcoming 2026 regulatory milestones, and potential launches for both treatment and prevention options. See our latest analysis for Gilead Sciences. Those HIV focused comments and recent licensing deals arrive after a 1 year total shareholder return of 37.54% and a 5 year total shareholder return of 119.96%, while the 3 month share price return of 2.92%...